Aligos Therapeutics, Inc. (ALGS) Reports Q1 Loss, Misses Revenue Estimates

Aligos Therapeutics, Inc. (ALGS) came out with a quarterly loss of $2.11 per share versus the Zacks Consensus Estimate of a loss of$ 2.80. This compares to loss of $5.50 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 24.64%. A quarter ago, it was expected that this company would post a loss of$ 1.91 per share when it actually produced a loss of $3.41, delivering a surprise of -78.53%.Over the last four quarters, the company h ...